On the other hand, osteopontin-CD44 binding has been shown to promote cleavage of CD44′s intracellular domain, leading to HIF-2α-dependent hypoxic signaling and maintenance of stem cell-like phenotypes in GBM [48]. The gene discussed is CD44; the disease is glioblastoma.